 Christopher Hoyte
Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poison Control Centers | 11 | 2023 | 84 | 3.740 |
Why?
| | Acetaminophen | 9 | 2023 | 241 | 2.260 |
Why?
| | Poisons | 5 | 2023 | 21 | 2.220 |
Why?
| | Analgesics, Non-Narcotic | 5 | 2023 | 120 | 1.820 |
Why?
| | Antivenins | 6 | 2022 | 56 | 1.800 |
Why?
| | Cannabis | 6 | 2023 | 384 | 1.490 |
Why?
| | Biguanides | 2 | 2023 | 12 | 1.480 |
Why?
| | Drug Overdose | 7 | 2022 | 292 | 1.410 |
Why?
| | Antidotes | 3 | 2022 | 135 | 1.290 |
Why?
| | Snake Bites | 4 | 2022 | 54 | 1.110 |
Why?
| | Anaphylaxis | 3 | 2023 | 143 | 1.080 |
Why?
| | Emergency Service, Hospital | 9 | 2023 | 1815 | 1.050 |
Why?
| | Chemical and Drug Induced Liver Injury | 3 | 2022 | 125 | 1.010 |
Why?
| | Methadone | 2 | 2023 | 77 | 1.000 |
Why?
| | Anticonvulsants | 2 | 2019 | 179 | 1.000 |
Why?
| | Spider Venoms | 2 | 2017 | 12 | 0.990 |
Why?
| | Substance-Related Disorders | 3 | 2019 | 947 | 0.930 |
Why?
| | Machine Learning | 3 | 2023 | 316 | 0.910 |
Why?
| | Energy Drinks | 2 | 2013 | 4 | 0.880 |
Why?
| | Viper Venoms | 3 | 2021 | 9 | 0.850 |
Why?
| | Abdominal Pain | 3 | 2023 | 135 | 0.830 |
Why?
| | Prescription Drugs | 2 | 2015 | 116 | 0.820 |
Why?
| | Analgesia | 1 | 2023 | 82 | 0.800 |
Why?
| | Metformin | 3 | 2022 | 276 | 0.800 |
Why?
| | Ethylene Glycol | 1 | 2021 | 9 | 0.780 |
Why?
| | Databases, Factual | 2 | 2023 | 1125 | 0.770 |
Why?
| | Designer Drugs | 2 | 2019 | 8 | 0.770 |
Why?
| | Alcoholic Intoxication | 1 | 2021 | 62 | 0.730 |
Why?
| | Cannabinoids | 4 | 2018 | 115 | 0.720 |
Why?
| | Spider Bites | 2 | 2017 | 10 | 0.690 |
Why?
| | Black Widow Spider | 2 | 2017 | 9 | 0.690 |
Why?
| | Adolescent | 20 | 2023 | 17837 | 0.680 |
Why?
| | Retrospective Studies | 20 | 2023 | 12544 | 0.650 |
Why?
| | Hyperammonemia | 1 | 2019 | 15 | 0.650 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2019 | 30 | 0.650 |
Why?
| | Heart Arrest | 3 | 2023 | 292 | 0.650 |
Why?
| | Valproic Acid | 1 | 2019 | 43 | 0.650 |
Why?
| | Garlic | 1 | 2019 | 3 | 0.640 |
Why?
| | Warts | 1 | 2019 | 4 | 0.640 |
Why?
| | Acetylcysteine | 2 | 2022 | 141 | 0.640 |
Why?
| | Occlusive Dressings | 1 | 2019 | 5 | 0.640 |
Why?
| | Carnitine | 1 | 2019 | 62 | 0.640 |
Why?
| | United States | 15 | 2023 | 12179 | 0.630 |
Why?
| | Foot Diseases | 1 | 2019 | 32 | 0.630 |
Why?
| | Venoms | 1 | 2018 | 30 | 0.630 |
Why?
| | Burns, Chemical | 1 | 2019 | 25 | 0.630 |
Why?
| | Dronabinol | 3 | 2023 | 118 | 0.630 |
Why?
| | Bites and Stings | 1 | 2018 | 30 | 0.620 |
Why?
| | Foot Injuries | 1 | 2019 | 36 | 0.610 |
Why?
| | Humans | 51 | 2023 | 114654 | 0.610 |
Why?
| | Seizures | 2 | 2018 | 340 | 0.600 |
Why?
| | Pyridoxine | 1 | 2018 | 28 | 0.590 |
Why?
| | Brain Diseases | 1 | 2019 | 124 | 0.590 |
Why?
| | Young Adult | 15 | 2023 | 10465 | 0.590 |
Why?
| | Vitamin B Complex | 1 | 2018 | 38 | 0.580 |
Why?
| | Toxicology | 1 | 2018 | 35 | 0.580 |
Why?
| | Isoniazid | 1 | 2018 | 52 | 0.580 |
Why?
| | Abdominal Injuries | 1 | 2019 | 108 | 0.580 |
Why?
| | Decision Trees | 5 | 2023 | 81 | 0.560 |
Why?
| | Renal Insufficiency | 1 | 2018 | 137 | 0.540 |
Why?
| | Child, Preschool | 13 | 2023 | 9111 | 0.540 |
Why?
| | Pain Measurement | 1 | 2018 | 444 | 0.540 |
Why?
| | Antitubercular Agents | 1 | 2018 | 169 | 0.530 |
Why?
| | Male | 27 | 2023 | 55579 | 0.520 |
Why?
| | Sports | 2 | 2015 | 187 | 0.520 |
Why?
| | Electrocardiography | 2 | 2015 | 560 | 0.500 |
Why?
| | Epilepsy | 2 | 2019 | 277 | 0.500 |
Why?
| | Phenethylamines | 1 | 2015 | 18 | 0.500 |
Why?
| | Piracetam | 1 | 2015 | 15 | 0.500 |
Why?
| | Hallucinations | 1 | 2015 | 30 | 0.500 |
Why?
| | Sodium Channel Blockers | 1 | 2015 | 23 | 0.490 |
Why?
| | Amitriptyline | 1 | 2015 | 21 | 0.490 |
Why?
| | Tachycardia | 1 | 2015 | 50 | 0.490 |
Why?
| | Acetamides | 1 | 2015 | 25 | 0.490 |
Why?
| | Sodium Channels | 1 | 2015 | 62 | 0.490 |
Why?
| | Food | 1 | 2016 | 160 | 0.480 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 68 | 0.470 |
Why?
| | Long QT Syndrome | 1 | 2015 | 59 | 0.470 |
Why?
| | Child | 19 | 2023 | 18407 | 0.470 |
Why?
| | Analgesics, Opioid | 4 | 2023 | 771 | 0.470 |
Why?
| | Performance-Enhancing Substances | 1 | 2013 | 7 | 0.430 |
Why?
| | Tachycardia, Ventricular | 1 | 2015 | 152 | 0.430 |
Why?
| | Diet Surveys | 1 | 2013 | 78 | 0.430 |
Why?
| | Caffeine | 1 | 2013 | 57 | 0.420 |
Why?
| | Ethylene Glycols | 1 | 2012 | 14 | 0.410 |
Why?
| | Adult | 17 | 2023 | 30542 | 0.410 |
Why?
| | Athletes | 1 | 2015 | 328 | 0.400 |
Why?
| | Hypoglycemic Agents | 2 | 2022 | 1012 | 0.390 |
Why?
| | Female | 21 | 2023 | 59488 | 0.390 |
Why?
| | Israel | 3 | 2019 | 40 | 0.360 |
Why?
| | Vomiting | 3 | 2022 | 123 | 0.340 |
Why?
| | Infant | 8 | 2022 | 7959 | 0.330 |
Why?
| | Acidosis | 2 | 2022 | 88 | 0.330 |
Why?
| | Infusions, Intravenous | 2 | 2019 | 371 | 0.300 |
Why?
| | Incidence | 3 | 2021 | 2312 | 0.300 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2023 | 222 | 0.290 |
Why?
| | Prognosis | 4 | 2022 | 3327 | 0.280 |
Why?
| | Colorado | 5 | 2019 | 4099 | 0.260 |
Why?
| | Sulfonylurea Compounds | 2 | 2023 | 44 | 0.260 |
Why?
| | Middle Aged | 9 | 2023 | 26732 | 0.260 |
Why?
| | Physical Examination | 2 | 2018 | 222 | 0.250 |
Why?
| | Reproducibility of Results | 2 | 2023 | 2762 | 0.250 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2018 | 2094 | 0.240 |
Why?
| | Treatment Outcome | 5 | 2019 | 9087 | 0.240 |
Why?
| | Viperidae | 2 | 2021 | 11 | 0.230 |
Why?
| | Animals | 10 | 2023 | 31698 | 0.230 |
Why?
| | Plant Poisoning | 1 | 2023 | 9 | 0.220 |
Why?
| | Poisoning | 2 | 2022 | 110 | 0.220 |
Why?
| | Benzodiazepines | 3 | 2023 | 116 | 0.220 |
Why?
| | Algorithms | 4 | 2023 | 1467 | 0.210 |
Why?
| | Foodborne Diseases | 1 | 2023 | 45 | 0.210 |
Why?
| | Support Vector Machine | 1 | 2022 | 34 | 0.200 |
Why?
| | Cohort Studies | 3 | 2022 | 4895 | 0.200 |
Why?
| | Epinephrine | 1 | 2023 | 163 | 0.200 |
Why?
| | Tertiary Healthcare | 2 | 2019 | 29 | 0.200 |
Why?
| | Hallucinogens | 1 | 2023 | 73 | 0.200 |
Why?
| | Health Facilities | 1 | 2022 | 72 | 0.200 |
Why?
| | Anesthesia | 1 | 2023 | 117 | 0.190 |
Why?
| | Crotalid Venoms | 1 | 2022 | 31 | 0.190 |
Why?
| | Age Factors | 2 | 2021 | 2894 | 0.190 |
Why?
| | Fentanyl | 1 | 2022 | 65 | 0.190 |
Why?
| | Prevalence | 2 | 2019 | 2250 | 0.190 |
Why?
| | Hospitals, Pediatric | 3 | 2019 | 480 | 0.180 |
Why?
| | Hypoglycemia | 2 | 2022 | 386 | 0.180 |
Why?
| | Pain Management | 1 | 2023 | 288 | 0.180 |
Why?
| | Tramadol | 1 | 2020 | 10 | 0.170 |
Why?
| | Mortality | 1 | 2021 | 287 | 0.170 |
Why?
| | Drug Administration Schedule | 2 | 2019 | 718 | 0.170 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 238 | 0.170 |
Why?
| | Bacitracin | 1 | 2019 | 6 | 0.160 |
Why?
| | Mediterranean Sea | 1 | 2018 | 1 | 0.160 |
Why?
| | Scyphozoa | 1 | 2018 | 1 | 0.160 |
Why?
| | Regression Analysis | 1 | 2021 | 944 | 0.160 |
Why?
| | Medicine, Traditional | 1 | 2019 | 23 | 0.160 |
Why?
| | Ammonia | 1 | 2019 | 56 | 0.160 |
Why?
| | Bandages | 1 | 2019 | 31 | 0.160 |
Why?
| | Hyperlactatemia | 1 | 2018 | 3 | 0.160 |
Why?
| | Cannabidiol | 1 | 2020 | 60 | 0.160 |
Why?
| | Anti-Infective Agents, Local | 1 | 2019 | 40 | 0.160 |
Why?
| | Debridement | 1 | 2019 | 73 | 0.160 |
Why?
| | Drug Packaging | 1 | 2019 | 42 | 0.150 |
Why?
| | Medical Marijuana | 1 | 2020 | 97 | 0.150 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2018 | 28 | 0.150 |
Why?
| | Substance Abuse Detection | 1 | 2018 | 62 | 0.150 |
Why?
| | Lead | 1 | 2018 | 43 | 0.150 |
Why?
| | Clinical Protocols | 1 | 2019 | 233 | 0.140 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 189 | 0.140 |
Why?
| | Blood Coagulation | 1 | 2019 | 218 | 0.140 |
Why?
| | Liver Failure, Acute | 1 | 2018 | 58 | 0.140 |
Why?
| | Administration, Intravenous | 1 | 2018 | 124 | 0.140 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2387 | 0.140 |
Why?
| | Aged | 5 | 2022 | 19068 | 0.140 |
Why?
| | Preventive Health Services | 1 | 2018 | 135 | 0.140 |
Why?
| | Physician's Role | 1 | 2018 | 197 | 0.130 |
Why?
| | Seasons | 1 | 2018 | 442 | 0.130 |
Why?
| | Acute Disease | 1 | 2019 | 910 | 0.130 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 951 | 0.130 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 165 | 0.130 |
Why?
| | Serotonin Syndrome | 1 | 2015 | 5 | 0.130 |
Why?
| | Marijuana Use | 1 | 2018 | 167 | 0.130 |
Why?
| | Clozapine | 1 | 2015 | 19 | 0.130 |
Why?
| | Age Distribution | 1 | 2016 | 342 | 0.130 |
Why?
| | Serotonin Antagonists | 1 | 2015 | 30 | 0.130 |
Why?
| | Sertraline | 1 | 2015 | 26 | 0.130 |
Why?
| | Critical Illness | 1 | 2020 | 644 | 0.120 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2015 | 32 | 0.120 |
Why?
| | Sodium Bicarbonate | 1 | 2015 | 40 | 0.120 |
Why?
| | Hemorrhage | 1 | 2019 | 620 | 0.120 |
Why?
| | Alzheimer Disease | 1 | 2020 | 442 | 0.120 |
Why?
| | Pandemics | 1 | 2022 | 1317 | 0.120 |
Why?
| | Aged, 80 and over | 2 | 2022 | 6345 | 0.110 |
Why?
| | Physician-Patient Relations | 1 | 2018 | 462 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 900 | 0.110 |
Why?
| | Drug Interactions | 1 | 2015 | 338 | 0.110 |
Why?
| | Risk Factors | 3 | 2015 | 8631 | 0.110 |
Why?
| | Indazoles | 1 | 2014 | 58 | 0.110 |
Why?
| | Hospital Mortality | 3 | 2023 | 776 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2018 | 489 | 0.110 |
Why?
| | Lithium | 2 | 2023 | 36 | 0.110 |
Why?
| | Diphenhydramine | 2 | 2023 | 30 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2017 | 770 | 0.100 |
Why?
| | Firearms | 1 | 2018 | 297 | 0.100 |
Why?
| | Athletic Performance | 1 | 2013 | 54 | 0.100 |
Why?
| | Calcium Channel Blockers | 2 | 2023 | 114 | 0.100 |
Why?
| | Suicide, Attempted | 1 | 2015 | 317 | 0.100 |
Why?
| | Kidney | 1 | 2018 | 1188 | 0.100 |
Why?
| | Mass Screening | 1 | 2018 | 1004 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2022 | 5044 | 0.090 |
Why?
| | Horses | 2 | 2022 | 96 | 0.090 |
Why?
| | Blood Glucose | 1 | 2020 | 1826 | 0.090 |
Why?
| | Universities | 1 | 2013 | 340 | 0.090 |
Why?
| | Data Collection | 1 | 2013 | 620 | 0.090 |
Why?
| | Eating | 2 | 2023 | 344 | 0.090 |
Why?
| | Registries | 3 | 2023 | 1767 | 0.090 |
Why?
| | Pyrazoles | 1 | 2012 | 362 | 0.080 |
Why?
| | Primary Health Care | 1 | 2018 | 1512 | 0.080 |
Why?
| | Students | 1 | 2013 | 502 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 2015 | 590 | 0.080 |
Why?
| | Pilot Projects | 2 | 2023 | 1373 | 0.080 |
Why?
| | Sex Factors | 1 | 2013 | 1715 | 0.070 |
Why?
| | Time Factors | 1 | 2018 | 6115 | 0.070 |
Why?
| | Naloxone | 2 | 2020 | 97 | 0.070 |
Why?
| | Shoulder Dislocation | 1 | 2008 | 48 | 0.070 |
Why?
| | Digoxin | 1 | 2023 | 26 | 0.060 |
Why?
| | Psychotropic Drugs | 1 | 2023 | 54 | 0.050 |
Why?
| | Bradycardia | 1 | 2023 | 48 | 0.050 |
Why?
| | Bupropion | 1 | 2022 | 39 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 264 | 0.050 |
Why?
| | Crotalus | 1 | 2022 | 18 | 0.050 |
Why?
| | Vertigo | 1 | 2022 | 37 | 0.050 |
Why?
| | Mice | 1 | 2018 | 14863 | 0.050 |
Why?
| | Tremor | 1 | 2022 | 45 | 0.050 |
Why?
| | Nausea | 1 | 2022 | 101 | 0.050 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2022 | 69 | 0.050 |
Why?
| | Dizziness | 1 | 2022 | 70 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 4622 | 0.050 |
Why?
| | Prospective Studies | 2 | 2023 | 6217 | 0.050 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2023 | 287 | 0.050 |
Why?
| | North America | 1 | 2022 | 256 | 0.050 |
Why?
| | Diarrhea | 1 | 2022 | 171 | 0.050 |
Why?
| | Coma | 1 | 2020 | 30 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 425 | 0.040 |
Why?
| | Nomograms | 1 | 2020 | 41 | 0.040 |
Why?
| | Aspirin | 1 | 2022 | 324 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2020 | 54 | 0.040 |
Why?
| | Sheep | 1 | 2022 | 764 | 0.040 |
Why?
| | Exercise | 1 | 2008 | 1644 | 0.040 |
Why?
| | Hyperglycemia | 1 | 2020 | 291 | 0.030 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 290 | 0.030 |
Why?
| | Edema | 1 | 2017 | 119 | 0.030 |
Why?
| | Near Drowning | 1 | 2015 | 4 | 0.030 |
Why?
| | Cardiac Tamponade | 1 | 2015 | 14 | 0.030 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2015 | 27 | 0.030 |
Why?
| | Water-Electrolyte Imbalance | 1 | 2015 | 26 | 0.030 |
Why?
| | Hypotension | 1 | 2017 | 116 | 0.030 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2015 | 64 | 0.030 |
Why?
| | Hypothermia | 1 | 2015 | 38 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 2015 | 181 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1842 | 0.030 |
Why?
| | Hospitalization | 1 | 2020 | 1750 | 0.020 |
Why?
| | Pain | 1 | 2017 | 705 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 307 | 0.020 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2015 | 444 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2371 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2015 | 749 | 0.020 |
Why?
| | Manipulation, Orthopedic | 1 | 2008 | 7 | 0.020 |
Why?
| | Shoulder Pain | 1 | 2008 | 32 | 0.020 |
Why?
| | Muscle Fatigue | 1 | 2008 | 94 | 0.020 |
Why?
| | Radiography | 1 | 2008 | 812 | 0.020 |
Why?
| | Pregnancy | 1 | 2015 | 5517 | 0.010 |
Why?
| | Athletic Injuries | 1 | 2008 | 456 | 0.010 |
Why?
|
|
Hoyte's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|